Skip to Main Content
Skip Nav Destination
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Low-income countries face a double burden of noncommunicable and communicable diseases, which further strains their limited resources. In response, the global community has prioritized four chronic noncommunicable diseases and four risk factors, not including neuropsychiatric disorders. Health systems play a key role in addressing the challenges of noncommunicable diseases, mental health and multimorbidity, but have failed to tackle this effectively. Noncommunicable disease as well as noncommunicable/communicable disease multimorbidity cannot be managed from only a biomedical perspective, but needs to include consideration of inequality and poverty. The health systems in low-income countries are currently failing in their management of individuals with single noncommunicable diseases; therefore, when a person is exposed to multiple risk factors and/or has multiple conditions, the health system cannot cope, leading to poor outcomes for individuals. Eleven elements were found to be necessary for diabetes care in low-income settings, and since diabetes makes a good tracer condition, these elements are presented for the issue of multimorbidity. They include organization of the health system, data collection, prevention, diagnostic tools and infrastructure, medicine procurement and supply, accessibility and affordability of medicines and care, healthcare workers, adherence issues, patient education and empowerment, community involvement and positive policy environment. Primary healthcare has been proposed as a solution, but there are numerous barriers to implementing this. Given health system constraints, there is a need to shift care back to the individual and their family for managing both the medical (self-care) and social aspects (e.g. stigma) of their conditions for better outcomes.

Low-income countries are defined by the World Bank as countries where income per capita is USD 1,035 or less [1]. This grouping includes 28 countries from sub-Saharan Africa, 5 from Asia, 3 from Central Asia and 1 in the Caribbean. Because of their low income, these countries spend on average only USD 22 per person per year on health [2]. While traditionally it was thought that the burden of disease in these countries was predominantly from communicable diseases, noncommunicable diseases represent 80% of deaths in low- and middle-income countries [3]. Noncommunicable diseases and poverty have a symbiotic relationship, with poverty increasing exposure to noncommunicable disease risk factors and actual noncommunicable diseases forcing individuals and households into poverty as the burden of the cost of care falls on the individual in these countries [3]. Noncommunicable diseases also impact health systems, economies and countries as a whole, as every 10% increase in noncommunicable diseases is associated with a 0.5% decrease in economic growth.

In September 2011, the United Nations held its second health-related general assembly on noncommunicable diseases after its 2001 meeting on HIV/AIDS. Four diseases were prioritized by the World Health Organization, namely cardiovascular diseases, cancer, chronic respiratory diseases and diabetes, which were chosen since they contribute the largest amount to morbidity and mortality [4]. In 2013, the World Health Organization's noncommunicable disease global action plan was endorsed and aims to provide a guide to attain nine voluntary global targets, including the overall goal of a 25% relative reduction in premature mortality from cardiovascular disease, cancer, diabetes and chronic respiratory disease by 2025 [4]. Although neuropsychiatric disorders contribute an estimated 13% of the global burden of disease [5], they are not formally included in the World Health Organization's global noncommunicable diseases action plan. Mental health is mentioned in the context of comprehensive care for noncommunicable diseases needing to include ‘primary prevention, early detection or screening, treatment, secondary prevention, rehabilitation and palliative care and attention to improving mental health' [4].

Health systems play a key role in addressing the challenges of noncommunicable diseases, mental health and multimorbidity. The management of these requires care be provided over a long period of time, which needs the input from a multidisciplinary team of healthcare workers, access to medicines and diagnostic tools, patient empowerment, and coordination of different elements of the health system [6].

With the number of people aged 65 years or above projected to increase from approximately 524 million in 2010 to about 1.5 billion in 2050, with the highest increase in developing countries, the issue of multimorbidity needs to be addressed. It is estimated that 1 in 4 adults suffer from multimorbidity, with most evidence coming from high-income countries [7]. Studies from low-income countries have found that 53.7% of people aged above 60 years had two or more chronic conditions in Bangladesh [8], 66.7% of people with diabetes also had hypertension in Cameroon [9] and in a nationally representative sample in South Africa it was found that 29.6% had two or more of the following conditions: hypertension, diabetes, asthma, depression, angina, stroke and arthritis [10].

Synergies to address and integrate care for communicable and noncommunicable diseases have not been addressed [11]. The links between the four main noncommunicable diseases are clearly established through their shared risk factors and high rates of comorbidity [8,9]. In low-income country settings, however, there is not only the existence of comorbidity of noncommunicable diseases, but also comorbidity of noncommunicable diseases with communicable disease [12].

The issue of multimorbidity can be linked to the causal pathways of the diseases [13]. For example, there is a link between a high burden of tuberculosis with smoking and harmful alcohol use [14,15,16], or mental health with sexual behavior, alcohol and tobacco use [17]. Another way of looking at multimorbidity is that having one condition means the individual is more likely to develop another [13]. For example, diabetes has been associated with a threefold incident risk of tuberculosis [18,19,20], HIV/AIDS causes Kaposi sarcoma and lymphoma [21], and people with HIV/AIDS are more likely to have mental disorders [22].

It is not only the condition that may lead to another condition, but also the treatments for these. One particular example relevant to low-income countries is the link between antiretroviral treatment and the metabolic syndrome [18], increased rate of cardiovascular risk factors [23], diabetes [24], and other cardiac, neurological and musculoskeletal conditions [25].

Finally, the last aspect is that proper management of both conditions is necessary in order to ensure good outcomes from each disease perspective. Good tuberculosis management is necessary for good diabetes management, and good diabetes management helps ensure the success of tuberculosis treatment; however, the medicines used to treat tuberculosis may worsen blood glucose control [19,20]. Management of depression is also necessary to ensure proper outcomes for noncommunicable diseases [26].

Addressing these situations needs to be done not only from a biomedical perspective, but also from a socioeconomic angle, taking into account inequalities and poverty. Table 1 details these interlinkages as well as the underlying issues of ageing and poverty.

Table 1

The interplay of multiple risk factors and diseases

The interplay of multiple risk factors and diseases
The interplay of multiple risk factors and diseases

The challenge in low-income countries is that there is a knowledge, treatment and outcome gap for noncommunicable diseases and multimorbidity. In Mozambique the prevalence of hypertension is 33.1%, but only 14.8% of people who have hypertension are aware they have it [27]. Of those aware, 51.9% receive treatment and of those receiving treatment, only 39.9% are controlling their hypertension. That means for every 100 people with hypertension, only 3 know they have the disease, receive treatment and have controlled hypertension. A nationally representative survey in South Africa found that despite the high prevalence of mental disorders and related disability, these conditions, especially depression, were less likely to be treated than physical disorders [28]. Data from the World Health Organization show that between 76 and 85% of people with mental health problems in low- and middle-income countries receive no treatment for their disorder and that resources for mental health are primarily assigned to mental hospitals [29].

The health systems in low-income countries are currently failing in their management of individuals with single conditions. Therefore, when a person has multiple conditions or multiple risk factors for these conditions, the health system is not organized in a manner that can face such a situation, which leads to poor outcomes for individuals.

A health system is defined as all the ‘activities whose primary purpose is to promote, restore and maintain health' [30]. Health systems have three main objectives: (1) to improve the health of the populations they serve, (2) respond to the population's expectations and (3) provide financial protection against the costs of ill-health [30].

Health systems do not work in isolation of the other sociopolitical elements of a given country, and therefore different models of health systems exist [31,32]. Certain key factors that health systems need to perform are procurement and supply of medicines, disposables and equipment, healthcare workers in sufficient numbers and with the right skills for the given population and disease burden, and sustainable financing and healthcare costs that do not overburden the poor and have a financial, budgetary and regulatory framework [31,32]. Research into diabetes in low-income countries [33] found that 11 elements were necessary for diabetes care. Diabetes makes a good tracer condition for health systems, from which the lessons learnt can be applied to other chronic conditions [34,35,36].

The first element is organization of the health system. Currently, health systems in low-income countries are not organized to manage noncommunicable disease, let alone individuals with multiple conditions, and are more focused on infectious diseases [37]. Many health system responses in low-income countries for HIV/AIDS and tuberculosis have focused on vertical programs only addressing these specific conditions and not tackling all the challenges faced by individuals in the health system [38]. Although these have shown some success, they fail to take a person-centered focus and do not manage all the conditions the individual may have, but only the one that is being funded, leading to fragmentation of healthcare [39]. This fragmentation also exists because care in urban areas is hospital based whereas in rural areas health services focus on a specific disease (e.g. HIV/AIDS) or selective services (e.g. maternal health) [39]. In parallel, the use of traditional medicine is widespread, with 80% of the population in Sub-Saharan Africa relying on this as their primary source of care [13], which has as of yet not been integrated for the management of noncommunicable diseases.

Although primary healthcare has been promoted in low-income countries, it has not been able to address the challenge of noncommunicable disease or play a role in prevention and health promotion [13,37]. Noncommunicable disease care is still the remit of specialists in specialist centers; for example, mental health in low-income countries is still predominantly focused on hospital care [40]. As these specialist centers are limited, this also causes problems for referrals and counterreferrals. Specifically for the issue of multimorbidity, the degree of overspecialization may mean multiple referrals, if feasible, are made to different specialists for the individual's multiple conditions.

When providing care for a person both over a long period of time and with multiple conditions, another element the health system needs to provide is data collection. Data are needed at all levels of the health system in order to inform policies, medicine procurement, and staffing and individual care. However, there is a general lack of quality health information systems in many low-income countries [37]. At the level of the individual, poor use of patient records means that previous consultations or other conditions are not taken into account, thus leading to an unstructured monitoring of clinical care [37]. There is also a lack of a recall system to ensure continuity of care [38]. In terms of studies, very few have looked at the issue of multimorbidity in low-income countries except for the issue of HIV/AIDS and tuberculosis.

Another area where studies are lacking from low-income countries and which is important for the issue of multimorbidity is prevention. As mentioned previously, primary healthcare in low-income countries does not fulfill its role in terms of prevention and health promotion [33]. This is linked to lack of training, human resources and culturally appropriate materials to ensure wider knowledge of noncommunicable disease and their risk factors in these settings. For example, asthma and chronic respiratory disease are underrecognized, underdiagnosed, undertreated and insufficiently prevented. With one of the main risk factors in low-income countries being the use of biomass fuel, local healthcare workers need the knowledge about these conditions in their specific context to enable them to play a preventive role and not only provide care [41]. The World Health Organization has also developed ‘best buys' for noncommunicable diseases for the four common risk factors (tobacco use, harmful use of alcohol, unhealthy diets and physical inactivity) and for cardiovascular disease, diabetes and cancer [42]. However, many low-income countries lack the capability of implementing, enforcing and sustaining these.

As prevention also includes screening measures, diagnostic tools and infrastructure are needed. However, health infrastructure is poor at all levels of the health system with, for example, 19 and 39% of primary healthcare facilities in Tanzania and Senegal, respectively, having access to electricity, water and sanitation [13]. In addition, basic equipment is lacking in these facilities and access to diagnostic tools for diabetes has been seen to be poor in low-income countries [43]. There are also financial constraints for the individual if they need to pay for the test as well as budget limits that impact a prescribers' ability to ask for certain tests [38].

Besides diagnostic tools and infrastructure, health systems need to be able to procure and supply medicines to manage multimorbidity.Looking at the issue of insulin in low-income countries, a variety of factors impact its procurement and supply, such as budget allocation for medicines, adequate buying procedures, quantification of needs, efficient procurement, efficient distribution, rational prescription and proper compliance [43].

Mental health is an example highlighting the challenge of medicine procurement and supply with such issues as prescription regulations, availability and use of certain treatments, and limited expenditure (low-income countries spend 10 times less than lower-middle and 1,547 less than high-income countries, respectively) [40]. Ultimately, all of these factors impact the affordability and accessibility of medicines. Accessibility is linked not only to distribution, but also to where the individual lives, with urban areas having better access than rural areas. In terms of affordability, government policies will impact this; for example, insulin is free in Nicaragua, while individuals have to pay for this in Mali because of the government policy of cost recovery [43]. Generic medicines to treat noncommunicable disease were found to be less available than medicines for communicable conditions in both the public (36.0 vs. 53.5%) and private sectors (54.7 vs. 66.2%) [44]. Specifically, antiasthmatic inhalers were available to 30.1% in the public sector and to 43.1% in the private sector. In terms of affordability, it has been found that 1 month of treatment for coronary heart disease costs 18.4 days' wages in Malawi while for insulin in Mali the annual cost represented 38% of per capita gross domestic product [43,45]. These conditions also place a huge financial burden on countries, with diabetes care representing 5% of the total budget for the Ministry of Health in Nicaragua and insulin representing 10% of the total medicines budget in Mozambique [43].

An essential element of the health system is healthcare workers. Issues of availability, rational use and training need to be addressed [46]. Low-income countries face a severe shortage of healthcare workers and the human resources present are inequitably distributed [13]. Specifically for mental health in the Africa region of the World Health Organization, there is significant variation in the number of psychiatrists, ranging from more than 10 per 100,000 to fewer than 1 per 100,000 [47]. There is also a low focus of these human resources on community care [40]. Overall, this problem is linked to an internal and external ‘brain drain' with doctors preferring the private over public sector, urban over rural areas, and tertiary levels of care versus primary care [48]. In addition, this internal brain drain to nongovernmental organizations specifically in the area of HIV/AIDS has impacted the availability of health professionals, e.g. 50% of medical graduates in Uganda were found to be working for an HIV-related nongovernmental organization [49].

It is important to define the role of different cadres of healthcare workers in managing noncommunicable disease and the role of specialists, such as in the initiation of treatment versus follow-up and continuation of treatment and how this is linked to treatment guidelines that are adapted to the local context or include the best clinical evidence. Another issue is actual training and how this training currently focuses on clinical management of certain diseases and not the issue of multimorbidity. Current training of health professionals, especially doctors, does not include the preventive role they can play.

Patient education is lacking both as health professionals are not trained in this area, have very little time for this, and also lack the materials and the means to deliver this. In addition, the view of certain diseases may impact how health professionals educate and empower their patients. For example, in some settings people with mental health problems are shackled and beaten because of traditional beliefs about the causes of these conditions [47]. Therefore, issues of stigma also need to be addressed not only for individuals with these conditions, but also in the wider community. There is also the issue of using Western concepts of disease. For example, Patel et al. [50] while studying depression in Zimbabwe found a variety of presentations and descriptions for this condition including supernatural causes. The health system may provide the majority of aspects that a person with a noncommunicable disease requires; however, the burden of care falls on the individual and their family as the majority of the time spent managing a noncommunicable disease is done outside of the health system [51].

Adherence is impacted by education about the condition and the financial burden of care. In low-income countries, patient education is lacking for noncommunicable disease and there is still a large financial burden of care. In a systematic review of adherence to cardiovascular medications in resource-limited settings, Bowry et al. [52] found that poor adherence was due to these factors as well as negative perceptions about medicines and their side effects.

Community involvement and patient associations can play a role in patient education and empowerment, thereby impacting adherence, with the proper support from the health system. Many types of patient organizations (e.g. diabetes associations) exist, with varying roles, such as advocacy, training for patients and healthcare workers, and acting as a support group for patients and families, as well as being a provider of care [53]. The 2011 Mental Health Atlas[40] found that 39% of low-income countries had associations compared with 80% of high-income countries. It is not only the number of these organizations that is important, but also that many of them focus on specific diseases, such as cancer societies, diabetes associations, etc.

Overall, the health system elements described above need to be present and supported by a positive policy environment. In low-income countries, there is a large reliance on external funding for specific disease programs [13]. Due to this it was found that 30% of countries do not have a specified budget for mental health [47]. In parallel, in order to address the issue of noncommunicable disease properly, a multisectorial approach is needed that not only includes the health sector, but also education, trade and agriculture [33]. For mental health there is also a need to include police and judicial systems. Although many low-income countries have started to develop national noncommunicable disease plans, these fail to recognize the true issue of multimorbidity and include mental health [54]. In low-income countries, only 48.7% of countries have a mental health policy in comparison to 77.1% of high-income countries [40].

There is both the need to address prevention and the wider determinants of noncommunicable disease as well as ensuring access to affordable care [37]. Primary healthcare has been proposed as a solution to address this challenge as it enables a shift in focus to managing the individual and not the specific condition; however, there are numerous barriers to delivery of noncommunicable disease interventions and not all noncommunicable disease interventions, due to their complexity, can be integrated in primary healthcare. This is even more relevant for multimorbidity whereby the complexity of the individual may mean that primary healthcare does not have the human and resource capacity to manage this.

Each level of the health system has a role to play in multimorbidity prevention and management, and thus needs certain materials and human resources to be available. Also, a certain level of organization and coordination between different levels of the health system and different sectors within the same institution (inpatient and outpatient services, pharmacy, laboratory, etc.) need to be in place for patient management and referral. Guidelines need to be developed and used as well as data to ensure efficient and effective care and help define referral pathways from different levels of the health system to avoid overuse of hospital care and ensure prompt referral to specialists only when needed.

An innovative approach to addressing the issue of noncommunicable diseases in low-income countries was a Twinning project between Diabetes UK (UK-based diabetes association) and Mozambique [55]. This project showed that by taking a systematic approach to developing diabetes care, including activities addressing all 11 elements presented above, it was able to improve healthcare worker knowledge, access to medicines and the government's response not only to diabetes, but also all noncommunicable diseases [56].

In looking at lessons from low-income countries in improving access to psychological treatments, Patel et al. [57] found that the two main barriers were a lack of human resources and the acceptance of the treatments proposed in different sociocultural contexts. The human resource challenge in low-income countries will not be solved quickly, and with the rising burden of noncommunicable disease and multimorbidity, solutions need to be found. Specifically looking at mental health, Petersen et al. [58] propose task-shifting to nonspecialists. These nonspecialists need to shift the power back to the individual and their family, and have informed and active individuals in their own care who are able to have a partnership with their healthcare providers [59].

One lesson from HIV/AIDS that may be useful for multimorbidity is to involve local communities actively [60]. As chronic diseases are mainly managed outside the formal health system, individuals need the skills to be able to care for themselves. Parallel to the ageing population, community-based care is necessary. This will of course require trained healthcare workers to be involved, but by involving civil society, traditional healers and other groups, the issues of knowledge and stigma can effectively be addressed, ensuring better management, medically and socially, and therefore better outcomes for people with multiple conditions.

1.
Country and Lending Groups. Washington, The World Bank, 2013.
2.
World Health Statistics 2009. Geneva, World Health Organization, 2009.
3.
Global Status Report on Noncommunicable Diseases. Geneva, World Health Organization, 2010.
4.
Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 - Revised Draft (version dated February 11, 2013). Geneva, World Health Organization, 2013.
5.
The Global Burden of Disease: 2004 Update. Geneva, World Health Organization, 2004.
6.
Nolte E, McKee M: Introduction; in Nolte E, McKee M (eds): Caring for People with Chronic Conditions: A Health System Perspective. Maidenhead, Open University Press, 2008.
7.
Alaba O, Chola L: The social determinants of multimorbidity in South Africa. Int J Equity Health 2013;12:63.
8.
Khanam MA, Streatfield PK, Kabir ZN, Qiu C, Cornelius C, Wahlin A: Prevalence and patterns of multimorbidity among elderly people in rural Bangladesh: a cross-sectional study. J Health Popul Nutr 2011;29:406-414.
9.
Choukem SP, Kengne AP, Dehayem YM, Simo NL, Mbanya JC: Hypertension in people with diabetes in sub-Saharan Africa: revealing the hidden face of the iceberg. Diabetes Res Clin Pract 2007;77:293-299.
10.
Negin J, Martiniuk A, Cumming RG, Naidoo N, Phaswana-Mafuya N, Madurai L, Williams S, Kowal P: Prevalence of HIV and chronic comorbidities among older adults. AIDS 2012;26(suppl 1):S55-S63.
11.
Marais BJ, Lonnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A: Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 2013;13:436-448.
12.
Maher D, Ford N, Unwin N: Priorities for developing countries in the global response to non-communicable diseases. Global Health 2012;8:14.
13.
Marquez PV, Farrington JL: The Challenge of Non-Communicable Diseases and Road Traffic Injuries in Sub-Saharan Africa. Washington, The World Bank, 2013.
14.
Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC: Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010;375:1814-1829.
15.
Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M: Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009;68:2240-2246.
16.
Brunet L, Pai M, Davids V, Ling D, Paradis G, Lenders L, Meldau R, van Zyl Smit R, Calligaro G, Allwood B, Dawson R, Dheda K: High prevalence of smoking among patients with suspected tuberculosis in South Africa. Eur Respir J 2011;38:139-146.
17.
Lundberg P, Rukundo G, Ashaba S, Thorson A, Allebeck P, Ostergren PO, Cantor-Graae E: Poor mental health and sexual risk behaviours in Uganda: a cross-sectional population-based study. BMC Public Health 2011;11:125.
18.
Young F, Critchley JA, Johnstone LK, Unwin NC: A review of co-morbidity between infectious and chronic disease in sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health 2009;5:9.
19.
Dooley KE, Chaisson RE: Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009;9:737-746.
20.
Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W: Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009;80:634-639.
21.
Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-3044.
22.
Freeman M, Patel V, Collins PY, Bertolote J: Integrating mental health in global initiatives for HIV/AIDS. Br J Psychiatry 2005;187:1-3.
23.
Muronya W, Sanga E, Talama G, Kumwenda JJ, van Oosterhout JJ: Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy. Trans R Soc Trop Med Hyg 2011;105:644-649.
24.
Rao MN, Mulligan K, Schambelan M: HIV infection and diabetes principles of diabetes mellitus; in Poretsky L (ed): Principles of Diabetes Mellitus, ed 2. New York, Springer, 2010, pp 617-642.
25.
Dawson R, Rom WN, Dheda K, Bateman ED: The new epidemic of non-communicable disease in people living with the human immunodeficiency virus. Public Health Action 2013;3:4-6.
26.
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B: Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-858.
27.
Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N: Hypertension prevalence, awareness, treatment, and control in Mozambique: urban/rural gap during epidemiological transition. Hypertension 2009;54:77-83.
28.
Suliman S, Stein DJ, Myer L, Williams DR, Seedat S: Disability and treatment of psychiatric and physical disorders in South Africa. J Nerv Ment Dis 2010;198:8-15.
29.
Draft Comprehensive Mental Health Action Plan 2013-2020. Geneva, World Health Organization, 2013.
30.
The World Health Report 2000 - Health Systems: Improving Performance. Geneva, World Health Organization, 2000.
31.
Strengthening Health Systems to Improve Health Outcomes: WHO's Framework for Action. Geneva, World Health Organization, 2007.
32.
Reich MR, Takemi K, Roberts MJ, Hsiao WC: Global action on health systems: a proposal for the Toyako G8 summit. Lancet 2008;371:865-869.
33.
Beran D, Yudkin J: Diabetes care in sub-Saharan Africa. Lancet 2006;368:1689-1695.
34.
Kessner D, Carolyn E, Singer J: Assessing health quality: the case for tracers. N Engl J Med 1973;288:189-194.
35.
Nolte E, Bain C, McKee M: Diabetes as a tracer condition in international benchmarking of health systems. Diabetes Care 2006;29:1007-1011.
36.
Beran D: Health systems and the management of chronic diseases: lessons from type 1 diabetes. Diabetes Manag 2012;2:1-13.
37.
Maher D, Harries AD, Zachariah R, Enarson D: A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Public Health 2009;9:355.
38.
Levitt NS, Steyn K, Dave J, Bradshaw D: Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings - insights from South Africa. Am J Clin Nutr 2011;94:1690S-1696S.
39.
World Health Report 2008: Primary Health Care - Now More than Ever. Geneva, World Health Organization, 2008.
40.
Mental Health Atlas 2011. Geneva, World Health Organization, 2011.
41.
van Gemert F, van der Molen T, Jones R, Chavannes N: The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J 2011;20:240-248.
42.
WHO, WEF: From Burden to ‘Best Buys': Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries. Geneva, World Economic Forum, 2011.
43.
Beran D, Yudkin JS: Looking beyond the issue of access to insulin. What is needed for proper diabetes care in resource poor settings. Diabetes Res Clin Pract 2010;88:217-221.
44.
Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HG, Laing RO: Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ 2011;89:412-421.
45.
Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, Leowski J, Ewen M: The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007;85:279-288.
46.
Wagner EH, Austin BT, Von Korff M: Organizing care for patients with chronic illness. Milbank Q 1996;74:511-544.
47.
WHO Resource Book on Mental Health, Human Rights and Legislation. Geneva, World Health Organization, 2005.
48.
Padarath A, Chamberlain C, McCoy D, Ntuli A, Rowson M, Loewenson R: Health personnel in Southern Africa: confronting maldistribution and brain drain. London, Regional Network for Equity in Health in Southern Africa, 2003.
49.
Bajunirwe F, Twesigye L, Zhang M, Kerry VB, Bangsberg DR: Influence of the US President's Emergency Plan for AIDS Relief (PEPfAR) on career choices and emigration of health-profession graduates from a Ugandan medical school: a cross-sectional study. BMJ Open 2013;3:pii, e002875.
50.
Patel V, Abas M, Broadhead J, Todd C, Reeler A: Depression in developing countries: lessons from Zimbabwe. BMJ 2001;322:482-484.
51.
Von Korff M, Glasgow R, Sharpe M: ABC of psychological medicine: organising care for chronic illness. BMJ 2002;325:92-94.
52.
Bowry AD, Shrank WH, Lee JL, Stedman M, Choudhry NK: A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med 2011;26:1479-1491.
53.
Diabetes Foundation Report on Insulin-Requiring Diabetes in Sub-Saharan Africa. London, International Insulin Foundation, 2005.
54.
Silva-Matos C, Beran D: Non-communicable diseases in Mozambique: risk factors, burden, response and outcomes to date. Global Health 2012;8:37.
55.
Yudkin JS, Holt RI, Silva-Matos C, Beran D: Twinning for better diabetes care: a model for improving healthcare for non-communicable diseases in resource-poor countries. Postgrad Med J 2009;85:1-2.
56.
Beran D, Silva Matos C, Yudkin JS: The Diabetes UK mozambique Twinning Programme. Results of improvements in diabetes care in Mozambique: a reassessment 6 years later using the Rapid Assessment Protocol for Insulin Access. Diabet Med 2010;27:855-861.
57.
Patel V, Chowdhary N, Rahman A, Verdeli H: Improving access to psychological treatments: lessons from developing countries. Behav Res Ther 2011;49:523-528.
58.
Petersen I, Lund C, Stein DJ: Optimizing mental health services in low-income and middle-income countries. Curr Opin Psychiatry 2011;24:318-323.
59.
Bodenheimer T, Lorig K, Holman H, Grumbach K: Patient self-management of chronic disease in primary care. JAMA 2002;288:2469-2475.
60.
Narayan KM, Ali MK, del Rio C, Koplan JP, Curran J: Global noncommunicable diseases - lessons from the HIV-AIDS experience. N Engl J Med 2011;365:876-878.

Send Email

Recipient(s) will receive an email with a link to 'Comorbidity of Mental and Physical Disorders > 33 - 41: Difficulties Facing the Provision of Care for Multimorbidity in Low-Income Countries' and will not need an account to access the content.

Subject: Comorbidity of Mental and Physical Disorders > 33 - 41: Difficulties Facing the Provision of Care for Multimorbidity in Low-Income Countries

(Optional message may have a maximum of 1000 characters.)

×
Close Modal

or Create an Account

Close Modal
Close Modal